These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4944129)

  • 21. [Vascular reactivity to cold. Study in normal subjects and in vascular acrosyndromes].
    Schmidt C; Schmitt J; Demange G
    J Mal Vasc; 1984; 9(1):29-33. PubMed ID: 6707532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experience with Complamin in peripheral circulation disorders].
    Wittenburg H
    Med Monatsschr; 1969 Dec; 23(12):558-61. PubMed ID: 5387170
    [No Abstract]   [Full Text] [Related]  

  • 23. Cosaldon for vascular disorders?
    Drug Ther Bull; 1972 Aug; 10(17):66-8. PubMed ID: 4570865
    [No Abstract]   [Full Text] [Related]  

  • 24. An experimentally controlled evaluation of the effect of inositol nicotinate upon the digital blood flow in patients with Raynaud's phenomenon.
    Holti G
    J Int Med Res; 1979; 7(6):473-83. PubMed ID: 391622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacodynamic observations on metronidazole therapy. Side effects in endocrine, metabolic and auto-immune disorders. 3. Anti-ischemic and anti-inflammatory action in peripheral vascular disorders.
    Taylor JA
    Proc West Pharmacol Soc; 1966; 9():37-9. PubMed ID: 4381145
    [No Abstract]   [Full Text] [Related]  

  • 26. [The influence of nicotinic acid on circulatory disorders of the lower extremities].
    Kirsch J; Kirsch J
    Landarzt; 1964 Dec; 40(35):1527-30. PubMed ID: 5826399
    [No Abstract]   [Full Text] [Related]  

  • 27. [On the therapy of central and peripheral blood circulation disorders].
    Weihrauch H
    Hippokrates; 1967 Sep; 38(18):739-42. PubMed ID: 5610064
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of bencyclane in obliterative arterial diseases].
    Kusztos D
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1419+. PubMed ID: 5536658
    [No Abstract]   [Full Text] [Related]  

  • 29. [Use of citrate nicamétate at high doses in cardiovascular surgery].
    Stankowiak C; Vandecasteele J; Soots G
    Lille Med; 1973 Nov; 18(9):1039-42. PubMed ID: 4211730
    [No Abstract]   [Full Text] [Related]  

  • 30. [On prolonged hemokinetic therapy of occlusive arterial diseases].
    Alegría A
    Med Klin; 1965 Jul; 60(28):1126-31. PubMed ID: 5835983
    [No Abstract]   [Full Text] [Related]  

  • 31. [Morpho-oscillography and rheography in examination of digital trophic disorders].
    Langeron P; Leuridan B
    Bull Soc Fr Dermatol Syphiligr; 1972; 79(1):74-9. PubMed ID: 4641746
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of angiodystrophic skin diseases with ginkgo-biloba].
    Nazzaro P; Di Carlo A
    Minerva Med; 1973 Nov; 64(79 Suppl):4198-200. PubMed ID: 4592297
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pharmacodynamic study on nicotinic acid and of one of its higher homologs (3-pyridyl acetic acid) in obliterative arteriopathies of the extremities].
    Spanò G; Saponaro A; Giordano G; Verde AM; Cosentino F; Dagianti A
    Boll Soc Ital Cardiol; 1967; 12(2):148-53. PubMed ID: 5606866
    [No Abstract]   [Full Text] [Related]  

  • 34. Suppression of Raynaud's phenomenon by methyldopa.
    Varadi DP; Lawrence AM
    Arch Intern Med; 1969 Jul; 124(1):13-8. PubMed ID: 5791479
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of nitroglycerin on finger artery blood pressure].
    Hänsgen K; Podhaisky H; Sternitzky R
    Vasa Suppl; 1991; 32():396-401. PubMed ID: 1771543
    [No Abstract]   [Full Text] [Related]  

  • 36. [The association of kallikrein and inositol hexanicotinate in the therapy of peripheral obliterating arteriopathy].
    D'Ayala Valva G
    Recenti Prog Med; 1966 Jun; 40(6):XIX-XXXVI. PubMed ID: 6014405
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical experience with bencyclane in the treatment of vascular obliterations in the limbs].
    Krakovskij NI; Taranovic VA
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1435+. PubMed ID: 5536665
    [No Abstract]   [Full Text] [Related]  

  • 38. [Attempts of treatment of peripheral blood circulation disorders including thromboembolic and hyperlipemic conditions with pentosanpolysulfoester (PPE)].
    Szirmai E; Celander DR
    Pharmazie; 1968 Sep; 23(9):501-2. PubMed ID: 4180427
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of peripheral circulatory disorders with a nicotinic acid derivative].
    Kienholz E
    Med Klin; 1965 Aug; 60(33):1321-4. PubMed ID: 5843335
    [No Abstract]   [Full Text] [Related]  

  • 40. [Complamine in obliterating peripheral circulatory disorders].
    Kusztos D; Bereczky M; Fono J
    Med Monatsschr; 1970 Mar; 24(3):127-8. PubMed ID: 5436974
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.